Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of the study is to see how safe and effective and tolerable the use of WelChol® is for type 2 diabetes when added to insulin alone or in combination with other anti-diabetic drugs
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Colesevelam hydrochloride | Drug |
| Measure | Description | Time Frame |
|---|---|---|
| - To assess the additional lowering of HbA1c achieved by | ||
| addition of WelChol® to current antidiabetic therapy |
| Measure | Description | Time Frame |
|---|---|---|
| To assess: the effects on fasting plasma glucose and | ||
| fructosamine; glycemic control response rate; effect on adiponectin; the effect on c-peptide; effect on c-reactive protein; effects on lipids and lipoproteins; the safety and tolerability of WelChol® as add- |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Tuscumbia | Alabama | United States | ||||
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 18663165 | Derived | Goldberg RB, Fonseca VA, Truitt KE, Jones MR. Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy. Arch Intern Med. 2008 Jul 28;168(14):1531-40. doi: 10.1001/archinte.168.14.1531. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| on therapy to patients receiving insulin alone or with |
| other oral drugs |
| Sierra Vista |
| Arizona |
| United States |
| Jonesboro | Arkansas | United States |
| Searcy | Arkansas | United States |
| Carmichael | California | United States |
| Concord | California | United States |
| Fullerton | California | United States |
| La Jolla | California | United States |
| San Diego | California | United States |
| West Hills | California | United States |
| Washington D.C. | District of Columbia | United States |
| Largo | Florida | United States |
| Miami | Florida | United States |
| New Port Richey | Florida | United States |
| West Palm Beach | Florida | United States |
| Chicago | Illinois | United States |
| Indianapolis | Indiana | United States |
| Lexington | Kentucky | United States |
| Louisville | Kentucky | United States |
| New Orleans | Louisiana | United States |
| Boston | Massachusetts | United States |
| Troy | Michigan | United States |
| Edina | Minnesota | United States |
| Chesterfield | Missouri | United States |
| Kansas City | Missouri | United States |
| St Louis | Missouri | United States |
| Bozeman | Montana | United States |
| Butte | Montana | United States |
| Englewood | New Jersey | United States |
| Charlotte | North Carolina | United States |
| Hickory | North Carolina | United States |
| Raleigh | North Carolina | United States |
| Statesville | North Carolina | United States |
| Winston-Salem | North Carolina | United States |
| Cincinnati | Ohio | United States |
| Marion | Ohio | United States |
| Portland | Oregon | United States |
| Beaver | Pennsylvania | United States |
| Charleston | South Carolina | United States |
| Bristol | Tennessee | United States |
| Morristown | Tennessee | United States |
| Dallas | Texas | United States |
| Houston | Texas | United States |
| Midland | Texas | United States |
| San Antonio | Texas | United States |
| Mexico City | Mexico |
| Lima | Peru |
| ID | Term |
|---|---|
| D003924 | Diabetes Mellitus, Type 2 |
| D003920 | Diabetes Mellitus |
| ID | Term |
|---|---|
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000069472 | Colesevelam Hydrochloride |
| ID | Term |
|---|---|
| D000499 | Allylamine |
| D000588 | Amines |
| D009930 | Organic Chemicals |
| D000498 | Allyl Compounds |
| D000475 | Alkenes |
| D006839 | Hydrocarbons, Acyclic |
| D006838 | Hydrocarbons |
Not provided
Not provided